Loading
NYSEHealthcareDrug Manufacturers - General
Latest quote
$258.45
+$3.67 · +1.44%
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Latest quote
$258.45
+$3.67 · +1.44%
After-hours
$257.8
−$0.65 · -0.25%
Oct 7, 7:57 PM ET
Regular session · ET · Market data may be delayed.
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Day range
Current $258.45
52-week range
Current $258.45
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
69
Undervalued
Sentiment
70
Bullish
Risk
16
Low Risk
Momentum
61
Gaining
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Day range
Current $258.45
52-week range
Current $258.45
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Jun 13, 2001 | 2:1 | — | — |
Stock split | Jun 12, 1996 | 2:1 | — | — |
Stock split | Jun 10, 1992 | 2:1 | — | — |
Stock split | May 11, 1989 | 2:1 | — | — |
Stock split | May 19, 1981 | 3:1 | — | — |
Stock split | May 18, 1970 | 3:1 | — | — |
Effective Jun 13, 2001
2:1
Effective Jun 12, 1996
2:1
Effective Jun 10, 1992
2:1
Effective May 11, 1989
2:1
Effective May 19, 1981
3:1
Effective May 18, 1970
3:1
Funds reporting this stock among their holdings, ordered by reported position size.
State Street SPDR S&P 500 ETF1557.T1.18T0.91%129.41T JPY0.09%¥123,000-0.32%
Vanguard Morningstar Total Stock Market ETFVTI20.34B0.87%2.3T USD0.03%$381.03-0.40%
Vanguard S&P 500 ETFVOO17B0.97%1.8T USD0.03%$714.34-0.26%
iShares Core S&P 500 ETFIVV8.18B0.91%899.63B USD0.03%$780.58-0.25%
State Street SPDR S&P 500 ETFSPY7.46B0.91%819.04B USD0.09%$777.22-0.24%
Vanguard Morningstar Value ETFVTV6.12B2.33%262.4B USD0.03%$218.21-0.37%
State Street Health Care Select Sector SPDR ETFXLV4.36B10.11%43.11B USD0.08%$168.81+1.03%
Vanguard Dividend Appreciation ETFVIG3.62B2.73%132.4B USD0.04%$236.99-0.32%State Street SPDR S&P 500 ETF1557.TVanguard Morningstar Total Stock Market ETFVTIVanguard S&P 500 ETFVOOiShares Core S&P 500 ETFIVVState Street SPDR S&P 500 ETFSPYVanguard Morningstar Value ETFVTVState Street Health Care Select Sector SPDR ETFXLVVanguard Dividend Appreciation ETFVIGAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
